시스타틴 C 측정 시장 : 제품 유형, 측정 방법, 샘플 유형, 설정, 용도, 최종 사용자별 - 세계 예측(2025-2030년)

The Cystatin C Assay Market was valued at USD 427.47 million in 2023, expected to reach USD 459.83 million in 2024, and is projected to grow at a CAGR of 7.24%, to USD 697.41 million by 2030.

A Cystatin C Assay is a medical diagnostic tool used to measure levels of cystatin C, a protein that reflects kidney function, providing a more accurate assessment than traditional creatinine tests. The necessity of this assay lies in its ability to offer earlier and precise information about declining renal function, making it essential in applications such as chronic kidney disease (CKD) monitoring, cardiovascular risk assessment, and research in nephrology. The end-use scope encompasses hospitals, diagnostic laboratories, and research institutes. The market is primarily driven by the rising prevalence of CKD, an aging population, and increasing demand for accurate diagnostics. Key influencing growth factors include advancements in assay technologies, heightened awareness about kidney health, and the integration of cystatin C testing within routine health check-ups. Latest opportunities are seen in emerging markets where healthcare infrastructure is improving and in regions witnessing a higher incidence of CKD due to lifestyle factors. Additionally, the development of combination assays that integrate genetic markers and cystatin C could tap into personalized medicine trends.

However, challenges like high costs, lack of awareness among medical professionals in developing regions, and variability in assay results due to non-standardized testing methods can impede market growth. Innovations are necessary in areas such as cost reduction through technological advances and enhancement of assay speed and accuracy. Investing in education and training for healthcare providers in emerging markets could better identify and promote the assay's benefits, broadening its adoption. The market is currently competitive and fragmented, driven by constant innovation and regulatory challenges, but opportunities for expansion exist through collaborations with biotech firms and focus on portable or point-of-care testing solutions. Overall, expanding applications in early diagnosis and chronic disease management will sustain and enhance market trajectory.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cystatin C Assay Market

The Cystatin C Assay Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising prevalence of kidney diseases and growing geriatric population
  • Progressive investments in healthcare infrastructures for renal disorders
• Market Restraints
  • High development costs of cystatin C assays and incidences of product recalls
• Market Opportunities
  • Advances in cystatin C assay testing
  • Emerging research for adoption of cystatin C assays as alternative to creatinine-based tests
• Market Challenges
  • Dearth of skilled lab professionals and technical challenges associated with cystatin C assay

Porter's Five Forces: A Strategic Tool for Navigating the Cystatin C Assay Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cystatin C Assay Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cystatin C Assay Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cystatin C Assay Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cystatin C Assay Market

A detailed market share analysis in the Cystatin C Assay Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cystatin C Assay Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cystatin C Assay Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Cystatin C Assay Market, highlighting leading vendors and their innovative profiles. These include Abbexa Limited, Abbott Laboratories, Abcam PLC, Advy Chemical Pvt. Ltd., Agilent Technologies, Inc., AOBIOUS Inc., Arbor Assays Inc., Aviva Systems Biology Corporation, BBI Solutions OEM Limited, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Biorbyt Ltd, BioVendor - Laboratorni medicina a.s., Boditech Med Inc., Cepham Life Sciences, Inc., Cusabio Technology LLC, DIALAB GmbH, DiaSys Diagnostic Systems GmbH, Diazyme Laboratories, Inc. by General Atomics, Eagle Biosciences, Inc., Elabscience Biotechnology Inc., Ethos Biosciences, Inc., Eurolyser Diagnostica GmbH by Mars, Incorporated, F. Hoffmann-La Roche Ltd, Fapon Biotech Inc., Fortress Diagnostics Ltd., Gentian Diagnostics ASA, Getein Biotech, Inc., ImmunoDiagnostics Limited, Kamiya Biomedical Company, Laboratory Corporation of America Holdings, Merck KGaA, Proteintech Group, Inc., PZ CORMAY S.A., Randox Laboratories Ltd., RayBiotech, Inc., Sekisui Diagnostics, LLC, Siemens Healthineers AG, Sino Biological, Inc., Thermo Fisher Scientific Inc., Tosoh Corporation, Weldon Biotech, and Zhejiang Kangte Biotechnology Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Cystatin C Assay Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Analyzer, Kits, and Reagents.
• Based on Method, market is studied across Chemiluminescence Immunoassay, Enzyme linked Immunosorbent Assay, Immunofluorescence Assay, Particle-enhanced Nephelometric Immunoassay, and Particle-enhanced Turbidimetric Immunoassay.
• Based on Sample Type, market is studied across Blood and Urine.
• Based on Setting, market is studied across Laboratory Setting and Point of Care Setting.
• Based on Application, market is studied across Diagnosis Use and Research & Development.
• Based on End-user, market is studied across Academic Research Centers, Diagnostic Laboratories, and Hospitals & Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of kidney diseases and growing geriatric population
    • 5.1.1.2. Progressive investments in healthcare infrastructures for renal disorders
  • 5.1.2. Restraints
    • 5.1.2.1. High development costs of cystatin C assays and incidences of product recalls
  • 5.1.3. Opportunities
    • 5.1.3.1. Advances in cystatin C assay testing
    • 5.1.3.2. Emerging research for adoption of cystatin C assays as alternative to creatinine-based tests
  • 5.1.4. Challenges
    • 5.1.4.1. Dearth of skilled lab professionals and technical challenges associated with cystatin C assay
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Consumer preference cystatin C analyzer for diagnosis and monitoring conditions
  • 5.2.2. Method: Expanding usage of enzyme-linked immunosorbent assay (ELISA) for cystatin C assays
  • 5.2.3. Setting: Expanding usage of point-of-care setting for cystatin C assays
  • 5.2.4. Sample Type: Significant role urine sample for cystatin C assay for measuring the amount of creatinine in a sample
  • 5.2.5. Application: Increasing application of cystatin C assays for diagnosis of renal function
  • 5.2.6. End-user: Expanding usage of cystatin C assays in academic research centers for studying biomarkers
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Cystatin C Assay Market, by Product

• 6.1. Introduction
• 6.2. Analyzer
• 6.3. Kits
• 6.4. Reagents

7. Cystatin C Assay Market, by Method

• 7.1. Introduction
• 7.2. Chemiluminescence Immunoassay
• 7.3. Enzyme linked Immunosorbent Assay
• 7.4. Immunofluorescence Assay
• 7.5. Particle-enhanced Nephelometric Immunoassay
• 7.6. Particle-enhanced Turbidimetric Immunoassay

8. Cystatin C Assay Market, by Sample Type

• 8.1. Introduction
• 8.2. Blood
• 8.3. Urine

9. Cystatin C Assay Market, by Setting

• 9.1. Introduction
• 9.2. Laboratory Setting
• 9.3. Point of Care Setting

10. Cystatin C Assay Market, by Application

• 10.1. Introduction
• 10.2. Diagnosis Use
• 10.3. Research & Development

11. Cystatin C Assay Market, by End-user

• 11.1. Introduction
• 11.2. Academic Research Centers
• 11.3. Diagnostic Laboratories
• 11.4. Hospitals & Clinics

12. Americas Cystatin C Assay Market

• 12.1. Introduction
• 12.2. Argentina
• 12.3. Brazil
• 12.4. Canada
• 12.5. Mexico
• 12.6. United States

13. Asia-Pacific Cystatin C Assay Market

• 13.1. Introduction
• 13.2. Australia
• 13.3. China
• 13.4. India
• 13.5. Indonesia
• 13.6. Japan
• 13.7. Malaysia
• 13.8. Philippines
• 13.9. Singapore
• 13.10. South Korea
• 13.11. Taiwan
• 13.12. Thailand
• 13.13. Vietnam

14. Europe, Middle East & Africa Cystatin C Assay Market

• 14.1. Introduction
• 14.2. Denmark
• 14.3. Egypt
• 14.4. Finland
• 14.5. France
• 14.6. Germany
• 14.7. Israel
• 14.8. Italy
• 14.9. Netherlands
• 14.10. Nigeria
• 14.11. Norway
• 14.12. Poland
• 14.13. Qatar
• 14.14. Russia
• 14.15. Saudi Arabia
• 14.16. South Africa
• 14.17. Spain
• 14.18. Sweden
• 14.19. Switzerland
• 14.20. Turkey
• 14.21. United Arab Emirates
• 14.22. United Kingdom

15. Competitive Landscape

• 15.1. Market Share Analysis, 2023
• 15.2. FPNV Positioning Matrix, 2023
• 15.3. Competitive Scenario Analysis
  • 15.3.1. Jana Care Raises USD 6 Million for Commercialisation of Self-Administered Blood Tests
  • 15.3.2. LordsMed Announces the Launch of its First Pathology Centre in Maharashtra
  • 15.3.3. Renalyse Closes a EUR 1 Million Funding Round with the Participation of GENESIS Ventures
  • 15.3.4. Renalytix Selects EVERSANA to Expand Commercialization of KidneyIntelX for Early-Stage Kidney Disease Prognosis Detection in Patients with Type 2 Diabetes
  • 15.3.5. New European Cystatin C Equation for eGFR May Be More Accurate
  • 15.3.6. Jana Care to Enter Collaboration with Roche to Develop and Distribute Blood Testing Platform to Improve Remote Care for Patients With Chronic Kidney and Heart Disease
  • 15.3.7. Gentian Diagnostics ASA Signs Distribution Agreement for Cystatin C
  • 15.3.8. Bloom Diagnostics Launches New Kidney Test

Companies Mentioned

• 1. Abbexa Limited
• 2. Abbott Laboratories
• 3. Abcam PLC
• 4. Advy Chemical Pvt. Ltd.
• 5. Agilent Technologies, Inc.
• 6. AOBIOUS Inc.
• 7. Arbor Assays Inc.
• 8. Aviva Systems Biology Corporation
• 9. BBI Solutions OEM Limited
• 10. Bio-Rad Laboratories, Inc.
• 11. Bio-Techne Corporation
• 12. Biorbyt Ltd
• 13. BioVendor - Laboratorni medicina a.s.
• 14. Boditech Med Inc.
• 15. Cepham Life Sciences, Inc.
• 16. Cusabio Technology LLC
• 17. DIALAB GmbH
• 18. DiaSys Diagnostic Systems GmbH
• 19. Diazyme Laboratories, Inc. by General Atomics
• 20. Eagle Biosciences, Inc.
• 21. Elabscience Biotechnology Inc.
• 22. Ethos Biosciences, Inc.
• 23. Eurolyser Diagnostica GmbH by Mars, Incorporated
• 24. F. Hoffmann-La Roche Ltd
• 25. Fapon Biotech Inc.
• 26. Fortress Diagnostics Ltd.
• 27. Gentian Diagnostics ASA
• 28. Getein Biotech, Inc.
• 29. ImmunoDiagnostics Limited
• 30. Kamiya Biomedical Company
• 31. Laboratory Corporation of America Holdings
• 32. Merck KGaA
• 33. Proteintech Group, Inc.
• 34. PZ CORMAY S.A.
• 35. Randox Laboratories Ltd.
• 36. RayBiotech, Inc.
• 37. Sekisui Diagnostics, LLC
• 38. Siemens Healthineers AG
• 39. Sino Biological, Inc.
• 40. Thermo Fisher Scientific Inc.
• 41. Tosoh Corporation
• 42. Weldon Biotech
• 43. Zhejiang Kangte Biotechnology Co., Ltd.